Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Ailliance Post-Market Clinical Study: All enablIng technoLogies, bioLogics, IDS, And Core spiNe produCt collEction

NCT05856370 is registered in ClinicalTrials.gov with Medtronic Spinal and Biologics as lead sponsor.

NCT NCT05856370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05856370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Ailliance Post-Market Clinical Study: All enablIng technoLogies, bioLogics, IDS, And Core spiNe produCt collEction
Lead sponsor
Medtronic Spinal and Biologics
Phase
Not applicable
Overall status
Recruiting
Start date
May 1, 2023
Completion date
May 31, 2031
Enrollment
1,000 (estimated)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

spinal deformity, spinal degenerative disorder, spinal fusion failure, spinal trauma, spinal tumor case